UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 336

Sortiert nach

Polycythemia is associated with bone loss and reduced osteoblast activity in mice

Osteoporosis international, 2016-04, Vol.27 (4), p.1559-1568

2016

Link zum Volltext

Verfügbarkeit prüfen

S102: OBLIGATE N‐TERMINAL BUT NOT C‐TERMINAL MONOFERRIC TRANSFERRIN AMELIORATES ANEMIA IN β‐THALASSEMIC MICE

HemaSphere, 2022-01, Vol.6 (Suppl), p.1-1

2022

Link zum Volltext

Verfügbarkeit prüfen

P1520: AN ACTIVIN RECEPTOR IIB LIGAND TRAP, IN COMBINATION WITH TMPRSS6 INDUCED IRON‐RESTRICTION, IS A SUPERIOR TREATMENT FOR CORRECTING Β‐THALASSEMIA IN MICE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1401-1402

2022

Link zum Volltext

Verfügbarkeit prüfen

S101: COMBINATION OF A LUSPATERCEPT‐LIKE DRUG (RAP‐GRL) AND TMPRSS6‐ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β‐THALASSEMIA

HemaSphere, 2022-01, Vol.6 (Suppl), p.1-1

2022

Link zum Volltext

Verfügbarkeit prüfen

P1509: BONE MARROW TFR2 GENETIC DELETION ABROGATES BLOOD TRANFUSION REQUIREMENT IN THE HBBTH1/TH2 Β‐THALASSEMIC MURINE MODEL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1390-1391

2022

Link zum Volltext

Verfügbarkeit prüfen

P1521: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

HemaSphere, 2022-06, Vol.6 (Suppl), p.1402-1403

2022

Link zum Volltext

Verfügbarkeit prüfen

S104: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

HemaSphere, 2022-01, Vol.6 (Suppl), p.2-3

2022

Link zum Volltext

Verfügbarkeit prüfen

Non-transfusion-dependent thalassemias

Haematologica (Roma), 2013-06, Vol.98 (6), p.833-844

2013

Link zum Volltext

Verfügbarkeit prüfen

Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing

Seminars in hematology, 1998-04, Vol.35 (2), p.112

1998

Link zum Volltext

Verfügbarkeit prüfen

Iron Loading and Overloading due to Ineffective Erythropoiesis

Advances in Hematology, 2010, Vol.2010, p.358283-8

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias

Advances in Hematology, 2010, Vol.2010, p.750643-9

2010

Link zum Volltext

Verfügbarkeit prüfen

Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia

Haematologica (Roma), 2016-01, Vol.101 (1), p.e8

2016

Link zum Volltext

Verfügbarkeit prüfen

The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice

Haematologica (Roma), 2013-03, Vol.98 (3), p.444-447

2013

Link zum Volltext

Verfügbarkeit prüfen

Iron Overload in Sickle Cell Disease

Advances in Hematology, 2010, Vol.2010, p.272940-9

2010

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between Iron Metabolism and Erythropoiesis

Advances in Hematology, 2010, Vol.2010, p.605435-12

2010

Link zum Volltext

Verfügbarkeit prüfen

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer

Blood, 2003-04, Vol.101 (8), p.2932-2939

2003

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene

Blood, 2002-03, Vol.99 (6), p.1902-1908

2002

Link zum Volltext

Verfügbarkeit prüfen

Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation

Haematologica (Roma), 2016-03, Vol.101 (3), p.297

2016

Link zum Volltext

Verfügbarkeit prüfen

Recent trends in the gene therapy of β-thalassemia

Journal of Blood Medicine, 2015-01, Vol.6 (default), p.69-85

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

Nature (London), 2000-07, Vol.406 (6791), p.82-86

2000

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Organization of a 450-kb Region of the Human X Chromosome in Xq28

Proceedings of the National Academy of Sciences - PNAS, 1993-12, Vol.90 (23), p.10977-10981

1993

Link zum Volltext

Verfügbarkeit prüfen

HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors

Molecular medicine (Cambridge, Mass.), 2015-01, Vol.21 (1), p.951-958

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy

Nature genetics, 1994-12, Vol.8 (4), p.323-327

1994

Link zum Volltext

Verfügbarkeit prüfen

In vivo gene transfer strategies to achieve partial correction of von Willebrand disease

Human gene therapy, 2012-06, Vol.23 (6), p.576

2012

Link zum Volltext

Verfügbarkeit prüfen

The cHS4 Insulator Increases the Probability of Retroviral Expression at Random Chromosomal Integration Sites

Journal of Virology, 2000-05, Vol.74 (10), p.4679-4687

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(304)

Publikationsform

Sprache

Englisch
(336)
Japanisch
(27)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Polycythemia is associated with bone loss and reduced osteoblast activity in mice

S102: OBLIGATE N‐TERMINAL BUT NOT C‐TERMINAL MONOFERRIC TRANSFERRIN AMELIORATES ANEMIA IN β‐THALASSEMIC MICE

P1520: AN ACTIVIN RECEPTOR IIB LIGAND TRAP, IN COMBINATION WITH TMPRSS6 INDUCED IRON‐RESTRICTION, IS A SUPERIOR TREATMENT FOR CORRECTING Β‐THALASSEMIA IN MICE

S101: COMBINATION OF A LUSPATERCEPT‐LIKE DRUG (RAP‐GRL) AND TMPRSS6‐ASO IS SUPERIOR TO EITHER DRUG ALONE FOR CORRECTING β‐THALASSEMIA

P1509: BONE MARROW TFR2 GENETIC DELETION ABROGATES BLOOD TRANFUSION REQUIREMENT IN THE HBBTH1/TH2 Β‐THALASSEMIC MURINE MODEL

P1521: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

S104: A SEVERE MOUSE MODEL OF ALPHA‐THALASSEMIA SHOWS ABNORMAL IRON METABOLISM, ERYTHROPOIESIS AND COAGULATION, AND CAN BE RESCUED BY A NOVEL GENE THERAPY APPROACH

Non-transfusion-dependent thalassemias

Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing

Iron Loading and Overloading due to Ineffective Erythropoiesis

Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias

Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia

The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice

Iron Overload in Sickle Cell Disease

Crosstalk between Iron Metabolism and Erythropoiesis

A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer

Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene

Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation

Recent trends in the gene therapy of β-thalassemia

Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin

Transcriptional Organization of a 450-kb Region of the Human X Chromosome in Xq28

HMGB1 Mediates Anemia of Inflammation in Murine Sepsis Survivors

Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy

In vivo gene transfer strategies to achieve partial correction of von Willebrand disease

The cHS4 Insulator Increases the Probability of Retroviral Expression at Random Chromosomal Integration Sites

Suchergebnisse filtern